Study group

Inclusion criteria

Control emmetropia

(n = 25)

No previous disease history, BCVA ≥ 20/20, intraocular pressure ≥ 10 to ≤21 mmHg, no abnormalities on dilated fundus examination and OCT scan

Control high myopia

(n = 20)

Spherical equivalent refractive error of >−6.0 diopters or axial length > 26.5 mm

Surgical treatment group (n = 46)

Stage 1-Eyes exhibiting Myopic Foveoschisis

Stage 2-Eyes with evidence of Foveoetinal Detachment

Stage 3-Eyes with evidence of a partial-or full-thickness macular hole

Stage 4-Eyes with posterior pole rhegmatogenous retinal detachment associated with an macular hole